Skip to main content

Table 5 Cost –effectiveness analysis (BGN)

From: Economic evaluation of continuous subcutaneous insulin infusion for children with diabetes - a pilot study: CSII application for children – economic evaluation

 

Total cost

Change in HbA1c

CER

ICER

Insulin

925,92

0.52 ± 0.41

1780,61

 

Pumps

6201,46

1.25 ± 0.99

4961,17

7226,77

Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us